Showing results (61-70 of 795) with videos related to
Sort By:
Pageof 80
BMC Medicine|June 16, 2016
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosisAlimuddin Zumla, Martin Rao, Ernest Dodoo, et al.Nature Reviews. Urology|September 25, 2019
Urogenital tuberculosis - epidemiology, pathogenesis and clinical featuresAsif Muneer, Bruce Macrae, Sriram Krishnamoorthy, et al.The Lancet. Respiratory Medicine|March 30, 2018
The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB eraKatherine Floyd, Philippe Glaziou, Alimuddin Zumla, et al.Nature Reviews. Immunology|August 2, 2005
Immune responses to tuberculosis in developing countries: implications for new vaccinesGraham A W Rook, Keertan Dheda, Alimuddin ZumlaThe Lancet. Infectious Diseases|September 6, 2014
Surveillance for emerging respiratory virusesJaffar A Al-Tawfiq, Alimuddin Zumla, Philippe Gautret, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 30, 2023
Middle East respiratory syndrome coronavirus-a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical originsEsam I Azhar, Thirumalaisamy P Velavan, Ikrormi Rungsung, et al.The Journal of Infectious Diseases|February 10, 2009
Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?Graham A W Rook, Rogelio Hernández-Pando, Alimuddin ZumlaCurrent Opinion in Pulmonary Medicine|February 23, 2013
Respiratory tract infections during the annual Hajj: potential risks and mitigation strategiesJaffar A Al-Tawfiq, Alimuddin Zumla, Ziad A MemishCurrent Opinion in Pulmonary Medicine|February 25, 2021
Host-directed therapies for COVID-19Markus Maeurer, Renata Ramalho, Fu-Sheng Wang, et al.Pageof 80